Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Dihexa for Sale > High Quality Dihexa CAS 1401708-83-5 Powder Fast Shipping Best Price
High Quality Dihexa CAS 1401708-83-5 Powder Fast Shipping Best Price buy - large image1
High Quality Dihexa CAS 1401708-83-5 Powder Fast Shipping Best Price buy - image1
High Quality Dihexa CAS 1401708-83-5 Powder Fast Shipping Best Price buy - image2
High Quality Dihexa CAS 1401708-83-5 Powder Fast Shipping Best Price buy - image3
High Quality Dihexa CAS 1401708-83-5 Powder Fast Shipping Best Price buy - image4

High Quality Dihexa CAS 1401708-83-5 Powder Fast Shipping Best Price

TDS 178 Inquiries

Unit Price: Get Latest Price
CAS No.:

1401708-83-5

Grade:

Pharmaceutical Grade

Content:

99.5%

Port:

Hangzhou

Brand:

HyperChem

Packaging:

1g/Bag

Price valid (until):

2024-12-01

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
10 days
Qualification:
Main Products:

Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements

  • Product Details

  • Seller Information

  • Inquiry History

  • Description

    Name

    Dihexa

    CAS number

    1401708-83-5

    Synonym

    PNB-0408; PNB 0408; PNB0408; Dihexa; N-hexanoic-Tyr-Ile-(6) aminohexanoic amide

    Description

    Dihexa is a compound of interest for its potential neuroprotective and cognitive-enhancing properties, stemming from its ability to promote synaptogenesis and neuroplasticity. While promising for future applications in cognitive enhancement and neurodegenerative disease treatment, its safety and efficacy require thorough evaluation through clinical trials. As with any experimental compound, individuals should exercise caution and consult healthcare professionals for guidance regarding its use.

    Structure

        Shop High Quality Dihexa CAS 1401708-83-5 Powder Fast Shipping Best Price-Detailed Image 1

    Molecular Formula

    C27H44N4O5

    Molecular Weight

    504.66 g/mol

    Appearance

    White powder

    Quality Standard

    99%

    Shipping Condition

    Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

    Storage Condition

    Dry, dark and at 2~8 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

    Shelf Life

    >2 years if stored properly

    Sample package

    Aluminium foil bag, Bottle

    Commercial package

    Aluminium Tin

    Origin

    China

    Dihexa More Info

    Dihexa (chemical name: N-hexanoic acid 2-(3,5-dimethyl-1H-pyrazol-1-yl)ethylamide) is a small peptide-like compound that has attracted attention for its potential neuroprotective and cognitive-enhancing properties. It was initially developed as part of research into compounds that could promote synaptogenesis (the formation of synapses between neurons) and possibly aid in treating neurodegenerative diseases and cognitive disorders.

    Chemical Structure

    Dihexa is characterized by its small molecular size and specific functional groups that allow it to interact with biological systems. It is chemically defined as a derivative of a pyrazole compound, and its structure suggests it may have properties that facilitate the crossing of the blood-brain barrier, which is essential for targeting central nervous system disorders.

    Mechanism of Action

    The precise mechanism of action of Dihexa is still under investigation, but it is believed to promote neuroplasticity through several pathways:

    1. Activation of Hepatocyte Growth Factor (HGF) : Dihexa has been shown to enhance the activity of HGF and its receptor c-Met, which are involved in promoting cell growth, survival, and neural development. This activation may support the regeneration of neurons and synaptic connections.
    2. Synaptogenesis : By encouraging the formation of new synapses, Dihexa may improve cognitive functions and memory by facilitating better communication between neurons.
    3. Neuroprotection : Its potential to protect neurons from damage could provide therapeutic benefits in conditions characterized by neurodegeneration or cognitive decline.

    Potential Applications

    1. Cognitive Enhancement : Due to its neuroplasticity-promoting effects, Dihexa is being studied for its potential role in enhancing cognitive function and memory in both healthy individuals and those with cognitive impairments.
    2. Neurodegenerative Diseases : Research is ongoing to evaluate its efficacy in treating conditions such as Alzheimer's disease and other forms of dementia, where enhancing synaptic function may slow disease progression.
    3. Mental Health Disorders : There is interest in exploring Dihexa’s therapeutic potential in various psychiatric disorders, where neuroplasticity-related mechanisms could play a crucial role.

    Safety and Side Effects

    As of now, comprehensive safety data on Dihexa is limited, particularly in human studies. Most of the research has been conducted in preclinical models, and further studies are needed to establish its safety profile. Potential side effects or adverse reactions are not well-documented, emphasizing the need for caution in its use.

    Research Status

    While Dihexa has shown promising effects in animal models, more extensive clinical trials are necessary to validate its effectiveness and safety for human use. Research into neuroprotective agents like Dihexa is ongoing, and it remains an area of active investigation within neuropharmacology.

    Conclusion

    Dihexa is a compound of interest for its potential neuroprotective and cognitive-enhancing properties, stemming from its ability to promote synaptogenesis and neuroplasticity. While promising for future applications in cognitive enhancement and neurodegenerative disease treatment, its safety and efficacy require thorough evaluation through clinical trials. As with any experimental compound, individuals should exercise caution and consult healthcare professionals for guidance regarding its use.


    Product Image

    Shop High Quality Oxytocin CAS 50-56-6-Detailed Image 2

    Shop USP Quality Standard API Finasteride Powder with CAS 98319-26-7-Detailed Image 3



    ECHEMI Editorial Reference

    Dihexa is a synthetic peptide-based compound and angiotensin IV analog. As a research and pharmaceutical raw material, Dihexa is characterized by its defined molecular structure and peptide properties. It is primarily used for research, analytical testing, compound evaluation, and pharmaceutical development.

    Certificates

    Basic Info
    Product Name:

    Dihexa

    Other Name:

    L-Isoleucinamide,N-(1-oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)-;N-(1-Oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)-L-isoleucinamide;Dihexa;N-Hexanoic-Tyr-Ile-(6)aminohexanoic amide

    CAS No.:

    1401708-83-5

    Molecular Formula:

    C27H44N4O5

    InChIKeys:

    InChIKey=XEUVNVNAVKZSPT-JTJYXVOQSA-N

    Molecular Weight:

    504.7

    Exact Mass:

    504.66

    Categories:

    Other Chemical Drugs

    Characteristics
    Density:

    1.111±0.06 g/cm3(Predicted)

    Boiling Point:

    866.2±65.0 °C(Predicted)

    Research
    Class:

    Angiotensin IV-derived oligopeptide / HGF-c-Met potentiator

    Status:

    Research compound — Not FDA approved

    Mechanism:

    A synthetic, orally active, blood-brain-barrier-permeable oligopeptide (Hexanoyl-Tyr-Ile-Ahx-NH₂) derived from angiotensin IV. Dihexa binds hepatocyte growth factor (HGF) with high affinity (Kd = 65 pM) and allosterically potentiates HGF activity at its receptor c-Met, promoting dendritic spinogenesis and synaptogenesis. In preclinical models it was reported to be seven orders of magnitude more potent than BDNF at promoting synapse formation. Note: the foundational 2014 paper (McCoy AT, et al. Neurobiol Learn Mem. 2014) was retracted in 2025.

    EC50 (HGF Binding KD):

    65 pM

    Activity note:

    Dihexa is an HGF potentiator, not a direct receptor agonist. It does not activate c-Met alone but markedly augments HGF-induced c-Met activation at low nanomolar HGF concentrations. Functional synaptogenic activity was reported at 10⁻¹°–10⁻⁻ M (original data now subject to retraction).

    Source:

    Original report: McCoy AT, et al. Neurobiol Learn Mem. 2014;115:112-120 (retracted 2025). Benoist CC, et al. J Pharmacol Exp Ther. 2014;351(3):628-637.

    Clinical Development:

    NCT04488419

    References
    PubChem:

    PubChem

    UNII:

    9WYX65A5C2

    Disclaimer:

    Dihexa is NOT FDA-approved or EMA-approved as a medicine. It is a research compound only. The foundational 2014 paper describing its synaptogenic potency was retracted in 2025. Its phosphate prodrug fosgonimeton failed a Phase 2/3 Alzheimer’s trial (LIFT-AD, 2024). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements

    Location:

    Rm. 803, Tower 4, LOFT49 Creative City Pioneer Zone, No.88 Jiru Rd. Gongshu Dist., Hangzhou, 310015 ZJ, China

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    10 days

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2013

    Company Certificates
    • Hangzhou Hyper Chemicals LimitedCertification Report by Bureau Veritas Certification Report by Bureau Veritas
    About HyperChem

    Established in 2013, Hyper Chem has exclusive tie-ups with leading manufacturers, supplying raw materials produced in GMP and ISO 9002 certified facilities, and provides high-quality ingredients and raw materials to meet the needs of a diverse range of pharmaceutical cosmetics ingredients and nootropic supplements companies worldwide.

    Our Competitiveness

    One-stop supply

    Wide Range Of products including pharmaceutical, Cosmetic Ingredients and nootropic supplements

    Among all the pharmaceuticals,

    90% of them with GMP certificates,

    85% of them with DMF files and

    50% of them passed FDA approval,

    30% get CEP certificate

    20% are new R&D products.

    Custom Repackaging Service


    We can efficiently repackage your material into sample sizes, custom batch-specific sizes, or semi-bulk package sizes according to your specifications. And ensures the product is packaged in a quality-controlled environment and will maintain its integrity throughout every stage of the process.

    Quality Control/Quality Assurance


    HyperChem is committed to delivering on its promises of top-quality products with verified quality data.

    All materials are vigorously inspected by the factory and/or outsourced analytical laboratories to ensure each and every lot meets or exceeds our reference standards.

    Trade assurance service with 100% payment protection, It is best achieved by delivering products and services 100% right the first time, on time, every time.

    Professional

    Transparent Communication

    Fast Reaction,

    Professional Suggestion

    Beyond Expectation.

    We have exclusive partnerships with research and production facilities across the country and we offer varied pharmaceutical services in the most cost-efficient way. The production facilities are GMP, WHO-GMP, EU GMP and US FDA approved and are backed by strong regulatory support such as Dossier, DMF, Tech Pack and relevant Stability studies for regulatory filings.

  • Inquiry History
    178 Inquiries
    Country Product Purchase Quantity Date Posted
    Canada

    Dihexa lyophilized 1401708-83-5

    1  Aug 23, 2026
    Canada

    Dihexa 1401708-83-5

    1 G Mar 8, 2026
    Bulgaria

    Customized peptides high purity Dihexa with fast shipping door to door CAS 1401708-83-5

    10 G May 27, 2025
    Australia

    Dihexa

    30 G Oct 19, 2026
    United States

    Dihexa

    500 G Aug 19, 2026
    United States

    Dihexa

    25 G Jan 26, 2025
    Russia

    DIHEXA

    50.00 G Aug 14, 2024
    Australia

    Dihexa

    2 G Oct 19, 2026
    United States

    dihexa

    10 MG Sep 28, 2026
    Spain

    Dihexa

    100 MG Aug 30, 2026
    United Arab Emirates

    Diheza

    1 G Aug 28, 2026
    Canada

    Dihexa

    130  Aug 12, 2026
    Brazil

    dihexa

    90 MG Aug 4, 2026
    United States

    Dihexa raw powder

    10 G Jul 26, 2026
    Singapore

    Dihexa

    10 PCS Jul 15, 2026
    United States

    Dihexa

    1 G Jul 11, 2026
    Sweden

    Dihexa

    10 PCS Jul 8, 2026
    Australia

    Dihexa

    1 MT Jul 2, 2026
    United States

    Dihexa

    10 G Jun 14, 2026
    Germany

    Dihexa

    1 G May 25, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.